Omada Health, which provides digital health tools for patients with chronic conditions, filed on Friday with the SEC to raise up to $100 million in an initial public offering.
Omada launched its initial program in diabetes prevention and weight health in 2012, and now offers cardiometabolic programs for prediabetes, diabetes, and hypertension; a physical therapy program to address MSK conditions; its GLP-1 Care Tracks; and behavioral health support across all programs. As of March 31, 2025, Omada had more than 2,000 customers and over 679,000 total members enrolled in one or more programs, having supported over one million members since launch.
The San Francisco, CA-based company was founded in 2011 and booked $190 million in revenue for the 12 months ended March 31, 2025. It plans to list on the Nasdaq under the symbol OMDA. Omada Health filed confidentially on June 24, 2024. Morgan Stanley, Goldman Sachs, J.P. Morgan, Barclays, and Evercore ISI are the joint bookrunners on the deal. No pricing terms were disclosed.
